ロード中...
Impact of Sarcopenia on Adverse Outcomes After Allogeneic Hematopoietic Cell Transplantation
BACKGROUND: High intensity treatments such as hematopoietic cell transplantation (HCT) can be curative for patients with hematologic malignancies, but this needs to be balanced by the high risk of nonrelapse mortality (NRM) during the first 2 years after HCT. Sarcopenia (low muscle mass) is associat...
保存先:
| 出版年: | J Natl Cancer Inst |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6695315/ https://ncbi.nlm.nih.gov/pubmed/30951603 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djy231 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|